10-Q 1 mantra-10q.htm FORM 10-Q mantra-10q.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 10-Q
 
 
x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended November 30, 2009
 
o TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE EXCHANGE ACT
 
For the transition period from _________ to _________
 
Commission File Number: 000-53461
 
 
Mantra Venture Group Ltd.
(Name of Small Business Issuer in its charter)
 
British Columbia
  
26-0592672
(state or other jurisdiction of incorporation or organization)
  
(I.R.S. Employer I.D. No.)
 
1205 – 207 West Hastings Street
Vancouver, British Columbia, Canada V6B 1H7
(Address of principal executive offices)
 
(604) 609 2898
Issuer’s telephone number
 
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was require to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  þ  No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o       Accelerated filer o    Non-accelerated filer o    Smaller reporting company þ
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  o   No þ
 
APPLICABLE ONLY TO CORPORATE ISSUERS
 
As of January 14, 2010, the registrant had 32,310,647 shares of common stock outstanding.
 
 
 
 
 
 
 
Table of Contents

 
 
 
 
 
The unaudited interim consolidated financial statements of Mantra Venture Group Ltd. (the “Company”, “Mantra”, “we”, “our”, “us”) follow. All currency references in this report are in US dollars unless otherwise noted.
 
 

 
MANTRA VENTURE GROUP LTD.
(A development stage company)
Consolidated financial statements
(Expressed in U.S. dollars)
November 30, 2009
 
 
 
 Index
Consolidated balance sheets
 F-1
Consolidated statements of operations
 F-2
Consolidated statements of cash flows
 F-3
Notes to the consolidated financial statements
 F-4


 
 
3
 
 
MANTRA VENTURE GROUP LTD.
(A development stage company)
Consolidated balance sheets
(Expressed in U.S. dollars)


   
November 30, 2009
$
(unaudited)
    
May 31, 2009
$
  
             
ASSETS
            
             
Current assets
            
             
Cash
     3,267       3,320  
Amounts receivable
     25,173       19,253  
Prepaid expenses and deposits
     –       6,536  
                 
Total current assets
     28,440       29,109  
                 
Property and equipment
     92,237       109,801  
                 
Total assets
     120,677       138,910  
                 
LIABILITIES AND STOCKHOLDERS’ DEFICIT
                
                 
Current liabilities
                
                 
Accounts payable and accrued liabilities (Note 3)
     506,398       224,893  
Due to related parties (Note 3)
     5,245       76,015  
Convertible debentures (Note 4)
     250,000       231,618  
                 
Total current liabilities
     761,643       532,526  
                 
Due to related parties (Note 3)
     127,644       –  
                 
Total liabilities
     889,287       532,526  
                 
Commitments (Note 5)
                
Subsequent events (Note 9)
                
                 
Stockholders’ deficit
                
                 
Preferred stock
Authorized: 20,000,000 shares, par value $0.00001
Issued and outstanding: Nil shares
     –       –  
                 
Common stock
Authorized: 100,000,000 shares, par value $0.00001
Issued and outstanding: 32,011,455 shares (May 31, 2009 – 23,452,661 shares)
     320       301  
                 
Additional paid-in capital
     3,820,447       3,431,286  
                 
Deficit accumulated during the development stage
     (4,589,377 )     (3,825,203 )
                 
Total stockholders’ deficit
     (768,610 )     (393,616 )
                 
Total liabilities and stockholders’ deficit
     120,677       138,910  
 
(The accompanying notes are an integral part of these consolidated financial statements)
 
 
 
F-1
 
 
MANTRA VENTURE GROUP LTD.
(A development stage company)
Consolidated statements of operations
(Expressed in U.S. dollars)
(unaudited)


   
Three Months Ended
November 30,
    
Six Months Ended
November 30,
    
Accumulated from
January 22, 2007
(Date of Inception)
to November 30,
  
     
2009
$
      
2008
$ 
      
2009
$ 
      
2008
$ 
    
2009
$
  
                                         
Revenues
     58,640       3,058       72,438       11,058       89,556  
                                         
Expenses
                                        
                                         
Business development
     7,131       9,851       59,890       11,300       272,113  
Consulting and advisory
     (4,838 )     11,581       23,203       35,355       428,210  
Depreciation and amortization
     8,782       13,351       17,564       18,305       75,398  
Foreign exchange loss
     13,510       –       18,583       –       15,326  
General and administrative (Note 3)
     7,590       37,627       30,234       78,298       341,415  
Management fees (Note 3)
     112,188       53,500       164,809       147,533       849,391  
Professional fees (Note 3)
     108,439       74,301       157,098       165,664       618,619  
Public listing costs
     6,865       5,683       10,943       7,500       200,286  
Rent
     12,917       –       26,383       –       135,973  
Research and development
     44,725       52,498       106,969       72,122       358,422  
Shareholder communications and awareness
     7,566       64,854       91,387       169,345       584,608  
Travel and promotion
     19,476       10,302       31,247       15,523       286,525  
Wages and benefits
     53,285       21,777       67,872       45,012       205,869  
Website and corporate identity
     –       –       –       –       195,451  
Write down of intangible assets
     –       –       –       –       37,815  
                                         
Total expenses
     397,636       355,325       806,182       765,957       4,605,421  
                                         
Loss before other expenses
     (338,996 )     (352,267 )     (733,744 )     (754,899 )     (4,515,865 )
                                         
Other expenses
                                        
                                         
Accretion of discounts on convertible debentures
     (7,655 )     (3,828 )     (18,382 )     (3,828 )     (45,930 )
Interest
     (5,747 )     (5,886 )     (12,048 )     (5,886 )     (27,582 )
                                         
Total other expenses
     (13,402 )     (9,714 )     (30,430 )     (9,714 )     (73,512 )
                                         
Net loss for the period
     (352,398 )     (361,981 )     (764,174 )     (764,613 )     (4,589,377 )
                                         
Loss per share, basic and diluted
     (0.01 )     (0.01 )     (0.02 )     (0.03 )        
                                         
Weighted average number of shares outstanding
     31,413,663       26,033,980       30,969,856       25,570,625          
 
(The accompanying notes are an integral part of these consolidated financial statements)
 
F-2
 
MANTRA VENTURE GROUP LTD.
(A development stage company)
Consolidated statements of cash flows
(Expressed in U.S. dollars)
(unaudited)
 

   
Six Months Ended
November 30,
    
Six Months Ended
November 30,
    
Accumulated from
January 22, 2007
(Date of Inception)
to November 30,
  
     
2009
$
      
2008
$
      
2009
$
  
                         
Operating activities
                        
                         
Net loss for the period
     (764,174 )     (764,613 )     (4,589,377 )
                         
Adjustments to reconcile net loss to net cash used in operating activities:
                        
Accretion of discounts on convertible debentures
     18,382       3,828       45,930  
Depreciation and amortization
     17,564       18,305       75,398  
Imputed interest
     –       3,160       –  
Stock-based compensation
     103,780       142,320       1,218,510  
Write-down of intangible assets
     –       –       37,815  
                         
Changes in operating assets and liabilities
                        
                         
Subscriptions receivable
     –       (95,000 )     –  
Amounts receivable
     (5,920 )     (11,860 )     (25,173 )
Prepaid expenses and deposits
     6,536       (20,351 )     –  
Other assets
     –       –       (12,000 )
Accounts payable and accrued liabilities
     296,505       45,773       679,015  
Due to related parties
     56,874       (38,626 )     132,889  
                         
Net cash used in operating activities
     (270,453 )     (717,064 )     (2,436,993 )
                         
Investing activities
                        
                         
Purchase of property and equipment
     –       (84,990 )     (155,635 )
                         
Net cash used in investing activities
     –       (84,990 )     (155,635 )
                         
Financing activities
                        
                         
Borrowings on related party debt
     –       98,595       –  
Payments on related party debt
     –       (74,206 )     –  
Proceeds from issuance of convertible debentures
     –       250,000       250,000  
Proceeds from issuance of common stock
     270,400       595,000       2,345,895  
                         
Net cash provided by financing activities
     270,400       869,389       2,595,895  
                         
Change in cash
     (53 )     67,335       3,267  
                         
Cash, beginning of period
     3,320       26,201       –  
                         
Cash, end of period
     3,267       93,536       3,267  
                         
Non-cash investing and financing activities:
                        
Common stock issued to settle accounts payable
     15,000       –       172,617  
Common stock issued and stock options granted for acquisition of intangible assets
     –       –       37,815  
                         
Supplemental disclosures:
                        
Interest paid
     –       –       –  
Income taxes paid
     –       –       –  
 
(The accompanying notes are an integral part of these consolidated financial statements)
 
F-3
 
MANTRA VENTURE GROUP LTD.
(A development stage company)
Notes to the consolidated financial statements
(Expressed in U.S. dollars)
November 30, 2009
(unaudited)
 
 
1. Basis of Presentation
 
The accompanying consolidated financial statements of Mantra Venture Group Ltd. (the “Company”) should be read in conjunction with the consolidated financial statements and accompanying notes filed with the U.S. Securities and Exchange Commission in the Company’s Annual Report on Form 10-K for the fiscal year ended May 31, 2009. In the opinion of management, the accompanying financial statements reflect all adjustments of a recurring nature considered necessary to present fairly the Company’s financial position and the results of its operations and its cash flows for the periods shown.

The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. The results of operations and cash flows for the periods shown are not necessarily indicative of the results to be expected for the full year.
 
2. Recent Accounting Pronouncements
 
In June 2009, the FASB issued guidance now codified as FASB ASC Topic 105, Generally Accepted Accounting Principles as the single source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with U.S. GAAP, aside from those issued by the SEC. ASC 105 does not change current U.S. GAAP, but is intended to simplify user access to all authoritative U.S. GAAP by providing all authoritative literature related to a particular topic in one place. The adoption of ASC 105 did not have a material impact on the Company’s financial statements, but did eliminate all references to pre-codification standards
 
In May 2009, FASB issued ASC 855, Subsequent Events, which establishes general standards of for the evaluation, recognition and disclosure of events and transactions that occur after the balance sheet date. Although there is new terminology, the standard is based on the same principles as those that currently exist in the auditing standards. The standard, which includes a new required disclosure of the date through which an entity has evaluated subsequent events, is effective for interim or annual periods ending after June 15, 2009. The adoption of ASC 855 did not have a material effect on the Company’s financial statements.
 
The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.
 
3. Related Party Transactions
 
a)  
During the six months ended November 30, 2009, the Company incurred management fees of $43,000 (2008 - $48,000) to the President of the Company.
 
b)  
During the six months ended November 30, 2009, the Company incurred administration fees of $24,458 (2008 - $19,670) to the spouse of the President of the Company.
 
c)  
During the six months ended November 30, 2009, the Company incurred professional fees of $12,000 (2008 - $nil) to a company controlled by the Chief Financial Officer of the Company.
 
d)  
During the six months ended August 31, 2009, the Company incurred management fees of $5,000 (2008 - $33,000) to a company controlled by the former Chief Financial Officer of the Company.
 
 
F-4
 
MANTRA VENTURE GROUP LTD.
(A development stage company)
Notes to the consolidated financial statements
(Expressed in U.S. dollars)
November 30, 2009
(unaudited)
 
 
3. Related Party Transactions (continued)
 
e)  
During the six months ended November 30, 2009, the Company incurred consulting fees of $63,180 (2008 - $nil) to directors of the Company.
 
f)  
As at November 30, 2009, the Company owes a total of $127,644 (May 31, 2009 - $72,825) to the President of the Company and a company controlled by the President of the Company. The amounts due are non-interest bearing and unsecured. As at May 31, 2009, the amounts owed were due on demand. On November 29, 2009, the repayment terms were amended and the amounts owed are now due on November 29, 2012. As at November 30, 2009, included in accounts payable and accrued liabilities is $41,560 owed to the President of the Company.
 
g)  
As at November 30, 2009, the Company owes a total of $5,245 (May 31, 2009 - $nil) to directors of the Company. The amounts due are non-interest bearing, unsecured and due on demand.
 
h)  
As at November 30, 2009, included in accounts payable and accrued liabilities is $15,750 (May 31, 2009) owed to a professional firm where the Chief Financial Officer of the Company is a partner.
 
i)  
As at November 30, 2009, included in accounts payable and accrued liabilities is $18,182 (May 31, 2009) owed to directors of the Company.

4. Convertible Debentures
 
On October 16, 17 and 28, 2008, the Company issued three convertible debentures for total proceeds of $250,000 which bear interest at 10% per annum, are unsecured and due one year from date of issuance. The unpaid amount of principal and accrued interest can be converted at any time at the holder’s option into 625,000 shares of the Company’s common stock at a price of $0.40 per share. The Company also issued 250,000 detachable, non-transferable share purchase warrants. Each share purchase warrant entitles the holder to purchase one additional share of the Company’s common stock for a period of two years from the date of the issue at an exercise price of $0.50 per share.
 
In accordance with EITF 98-5, “Accounting for Convertible Securities with Beneficial Conversion Features or Contingently Adjustable Conversion Ratios”, the Company determined that the convertible debentures contained no embedded beneficial conversion feature as the convertible debentures were issued with a conversion price higher than the fair market value of the Company’s common shares at the time of issuance.
 
In accordance with EITF 00-27, “Application of issue No. 98-5 to Certain Convertible Instruments”, the Company allocated the proceeds of issuance between the convertible debt and the detachable share purchase warrants based on their relative fair values. Accordingly, the Company recognized the relative fair value of the share purchase warrants of $45,930 as additional paid-in capital and an equivalent discount against the convertible debentures. During the period ended November 30, 2009, the Company has recorded accretion expense of $18,382, increasing the carrying value of the convertible debentures to $250,000.

5. Commitments
 
a)  
The Company entered into a premises agreement whereby it is committed to pay $1,000 per month expiring on December 15, 2009.
 
b)  
On October 1, 2009, the Company entered into an agreement with an individual to become the Chief Financial Officer of the Company for $6,000 per month expiring on September 30, 2010.
 
 
F-5
 
MANTRA VENTURE GROUP LTD.
(A development stage company)
Notes to the consolidated financial statements
(Expressed in U.S. dollars)
November 30, 2009
(unaudited)
 
5. Commitments (continued)
 
c)  
On September 2, 2009, the Company entered into an agreement with a company to acquire a worldwide, exclusive license for the Mixed Reactant Flow-By Fuel Cell technology. The term of the agreement is for twenty years or the expiry of the last patent licensed under the agreement, whichever is later. The Company agreed to pay the licensor the following license fees:
 
·  
an initial license fee of Cdn$10,000 payable in two instalments: Cdn$5,000 upon execution of the agreement (paid) and Cdn$5,000 within thirty days of September 2, 2009 (accrued);
·  
a further license fee of Cdn$15,000 to be paid within ninety days of September 2, 2009; and
·  
an annual license fee, payable annually on the anniversary of the date of the agreement as follows:
 
September 1, 2010
Cdn$10,000
September 1, 2011
Cdn$20,000
September 1, 2012
Cdn$30,000
September 1, 2013
Cdn$40,000
September 1, 2014 and each successive anniversary
Cdn$50,000
 
The Company is to pay the licensor a royalty calculated as 2% of the gross revenue and 15% of any and all consideration directly or indirectly received by the Company from the grant of any sublicense rights. The Company will pay interest at a rate of 1% per month on any amounts past due. In addition, the Company is responsible for the timely payment of all future costs relating to patent expenses and any new or useful art, process, machine, manufacture or composition of matter arising out of any licensor improvements or joint improvements licensed under this agreement and identified by the licensor as potentially patentable. The Company must also invest a minimum of Cdn$250,000 in research and development directly associated with the technology.
 
6. Common Stock
 
a)  
On June 1, 2009, the Company issued 100,000 shares of common stock with a fair value of $24,000 for services rendered.
 
b)  
On July 3, 2009, the Company issued 25,000 shares of common stock with a fair value of $6,000 for services rendered.
 
c)  
On July 16, 2009, the Company issued 466,334 units at $0.15 per unit for proceeds of $69,950. Each unit consisted of one share of common stock and one non-transferable share purchase warrant to purchase one additional share of common stock at an exercise price of $0.30 per share expiring on the earlier of two years or five business days after the Company’s common stock trades at least one time per day on the FINRA Over the Counter Bulletin Board at a price at or above $0.60 per share for seven consecutive trading days.
 
d)  
On July 24, 2009, the Company issued 18,000 units at $0.15 per unit for proceeds of $2,700. Each unit consisted of one share of common stock and one non-transferable share purchase warrant to purchase one additional share of common stock at an exercise price of $0.30 per share expiring on the earlier of two years or five business days after the Company’s common stock trades at least one time per day on the FINRA Over the Counter Bulletin Board at a price at or above $0.60 per share for seven consecutive trading days
 
 
F-6
 
MANTRA VENTURE GROUP LTD.
(A development stage company)
Notes to the consolidated financial statements
(Expressed in U.S. dollars)
November 30, 2009
(unaudited)
 
 
6. Common Stock (continued)
 
e)  
On July 24, 2009, the Company issued 100,000 units with a fair value of $15,000 to settle accounts payable. Each unit consisted of one common share and one-half non-transferrable warrant to purchase one additional share of common stock at an exercise price of $0.30 per share expiring on the earlier of two years or five business days after the Company’s common stock trades at least one time per day on the FINRA Over the Counter Bulletin Board at a price at or above $0.60 per share for seven consecutive trading days.
 
f)  
On August 17, 2009, the Company issued 25,000 shares of common stock with a fair value of $7,250 for services rendered.
 
g)  
On August 24, 2009, the Company issued 594,333 units at $0.15 per unit for proceeds of $89,150. Each unit consisted of one share of common stock and one non-transferable share purchase warrant to purchase one additional share of common stock at an exercise price of $0.30 per share expiring on the earlier of two years or five business days after the Company’s common stock trades at least one time per day on the FINRA Over the Counter Bulletin Board at a price at or above $0.60 per share for seven consecutive trading days.
 
h)  
On October 15, 2009, the Company issued 68,000 units at $0.15 per unit for proceeds of $10,200. Each unit consisted of one share of common stock and one non-transferable share purchase warrant to purchase one additional share of common stock at an exercise price of $0.30 per share expiring on the earlier of two years or five business days after the Company’s common stock trades at least one time per day on the FINRA Over the Counter Bulletin Board at a price at or above $0.60 per share for seven consecutive trading days.
 
i)  
On November 27, 2009, the Company issued 556,000 units at $0.15 per unit for proceeds of $83,400. Each unit consisted of one share of common stock and one non-transferable share purchase warrant to purchase one additional share of common stock at an exercise price of $0.30 per share expiring on the earlier of two years or five business days after the Company’s common stock trades at least one time per day on the FINRA Over the Counter Bulletin Board at a price at or above $0.60 per share for seven consecutive trading days.

7. Stock Options
 
The following table summarizes the continuity of the Company’s stock options:
 
 
Number of options
Weighted average exercise price
$
Weighted average remaining
contractual life (years)
Aggregate intrinsic value
$
         
Outstanding, May 31, 2009
2,800,000
0.32
    
         
    Granted
708,333
0.21
    
    Cancelled
(1,475,000)
0.28
    
         
Outstanding and exercisable, November 30, 2009
2,033,333
0.31
1.0
3,000
 

 
F-7
 
MANTRA VENTURE GROUP LTD.
(A development stage company)
Notes to the consolidated financial statements
(Expressed in U.S. dollars)
November 30, 2009
(unaudited)
 
 
7. Stock Options (continued)
 
Additional information regarding stock options as of November 30, 2009, is as follows:
 
Number of Options
Exercise Price
$
Expiry Date
     
100,000
0.25
January 1, 2010
50,000
0.40
December 13, 2009
200,000
0.75
March 5, 2010
75,000
0.45
April 25, 2010
100,000
0.25
July 16, 2010
375,000
0.30
January 1, 2011
75,000
0.27
February 10, 2011
100,000
0.30
October 6, 2010
250,000
0.25
November 1, 2012
75,000
0.15
June 1, 2011
233,333
0.24
September 21, 2010
400,000
0.20
October 1, 2010
     
2,033,333
    
 
The fair values for stock options granted have been estimated using the Black-Scholes option pricing model assuming no expected dividends and the following weighted average assumptions:
 
   
Six months ended
November 30,
2009
    
Six months ended
November 30,
2008
  
             
Risk-free Interest rate
     0.39 %     2.26 %
Expected life (in years)
     1.0       0.9  
Expected volatility
     92 %     96 %
 
The weighted average fair value of the stock options granted during 2009 was $0.10 per option.
 
As of November 30, 2009, the Company has no unrecognized compensation expense relating to unvested options.

8. Share Purchase Warrants
 
The following table summarizes the continuity of share purchase warrants:
 
   
Number of Warrants
    
Weighted Average
Exercise Price
$
  
Balance, May 31, 2009
     6,576,358       0.31  
                 
Issued
     1,802,667       0.30  
Expired
     (2,510,000 )     0.21  
                 
Balance, November 30, 2009
     5,869,025       0.35  
 
 
F-8
 
MANTRA VENTURE GROUP LTD.
(A development stage company)
Notes to the consolidated financial statements
(Expressed in U.S. dollars)
November 30, 2009
(unaudited)
 
 
8. Share Purchase Warrants (continued)
 
As at November 30, 2009, the following share purchase warrants were outstanding:
 
Number of Warrants
Exercise Price
$
Expiry Date
     
45,000
0.50
December 1, 2009
35,000
0.50
December 5, 2009
221,250
0.50
December 10, 2009
37,500
0.50
December 18, 2009
100,000
0.50
February 28, 2010
75,000
0.50
May 1, 2010
200,000
0.50
October 16, 2010
50,000
0.50
October 17, 2010
610,000
0.50
November 30, 2010
199,998
0.40
March 10, 2011
859,625
0.30
April 1, 2011
71,152
0.30
April 3, 2011
292,500
0.30
April 6, 2011
860,000
0.30
April 16, 2011
88,000
0.30
May 20, 2011
321,333
0.30
May 28, 2011
466,334
0.30
July 16, 2011
118,000
0.30
July 24, 2011
594,333
0.30
August 24, 2011
68,000
0.30
October 15, 2011
556,000
0.30
November 27, 2011
     
5,869,025
    


9. Subsequent Events
 
The Company has evaluated all events or transactions that occurred after November 30, 2009 through to January 14, 2010.
 
a)  
On December 3, 2009, the Company issued 400,000 shares of common stock to a consultant who is to provide marketing services. On January 11, 2010, the Company cancelled these shares.

b)  
On December 4, 2009, the Company issued 33,334 units at $0.15 per unit for proceeds of $5,000.  Each unit consisted of one share of common stock and one non-transferable share purchase warrant to purchase one additional share of common stock at an exercise price of $0.30 per share expiring on the earlier of two years or five business days after the Company’s common stock trades at least one time per day on the FINRA Over the Counter Bulletin Board at a price at or above $0.60 per share for seven consecutive trading days.

c)  
On December 11, 2009, the Company issued 299,192 shares of common stock to settle $50,862 of accounts payable.
 
 
F-9
 
 
 
Forward Looking Statements
 
This quarterly report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including "could", "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" and the negative of these terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially.
 
While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report.
 
Business Overview
 
We are building a portfolio of companies and technologies that mitigate negative environmental and health consequences that arise from the production of energy and the consumption of resources. On November 2, 2007, through our wholly owned subsidiary, Mantra Energy Alternatives Ltd., we entered into a technology assignment agreement with 0798465 BC Ltd. whereby we acquired 100% ownership of an invention for the electro-reduction of carbon dioxide.  
 
Our mission is to develop and commercialize alternative energy technologies and services to enable the sustainable consumption, production and management of resources on residential, commercial and industrial scales. We plan to develop or acquire technologies and services which include electrical power system monitoring technology, wind farm electricity generation, online retail of environmental sustainability solutions through a carbon reduction marketplace, and media solutions to promote awareness of corporate actions that support the environment. To carry out our business strategy we intend to acquire or license from third parties technologies that require further development before they can be brought to market. We also intend to develop such technologies ourselves, and we anticipate that to complete commercialization of some technologies we will enter into joint ventures, partnerships, or other strategic relationships with third parties who have expertise that we may require. We also plan to enter into formal relationships with consultants, contractors, retailers and manufacturers who specialize in the areas of environmental sustainability in order to carry out our online retail strategy.
 
Results of Operations for the Period From January 22, 2007 (Date of Inception) to November 30, 2009 and for the Three Months Ended November 30, 2009.
 
Revenues

We have had limited operational history since our inception on January 22, 2007. From our inception on January 22, 2007 to November 30, 2009 we have generated $89,556 in revenues.  For the three months ended November 30, 2009 we generated revenues of $58,640 compared to $3,058 during the same period in 2008.  The increase in revenue is attributable to a government grant we received in the quarter.  Since our inception on January 22, 2007 to November 30, 2009, we have an accumulated deficit of $4,589,377. We anticipate that we will incur substantial losses over the next year and our ability to generate additional revenues in the next 12 months remains uncertain.
 
 
4
 

 
Expenses

We accumulated total expenses of $4,605,421 from the date of our inception to November 30, 2009, including $358,422 in research and development costs, $849,391 in management fees, $618,619 in professional fees, $584,608 in shareholder communications and awareness, and $428,210 in consulting and advisory expenses.

For the three months ended November 30, 2009, we incurred total expenses of $397,636 including $44,725 in research and development costs, $112,188 in management fees, $108,439 in professional fees, $7,566 in shareholder communications and awareness, and $53,285 in wages and benefits.

By comparison, our total operating expenses for the three months ended November 30, 2008 were $355,325 including $52,498 in research and development costs, $53,500 in management fees, $74,301 in professional fees, $64,854 in shareholder communications and awareness, and $21,777 in wages and benefits.

Net Loss

Since our inception on January 22, 2007 to November 30, 2009, we have incurred a net loss of $4,589,377. For the three months ended November 30, 2009, we incurred a net loss of $352,398 compared to our net loss of $361,981 for the same period in 2008.  Our net loss per share for the three months ended November 30, 2009 was $0.01; the same as for the three months ended November 30, 2008.
 
Results of Operations for the Six Months Ended November 30, 2009 compared to November 30, 2008.
 
Revenues

For the six months ended November 30, 2009 we generated revenues of $72,438 compared to $11,058 during the same period in 2008.

Expenses

For the six months ended November 30, 2009, we incurred total expenses of $806,182 including $106,969 in research and development costs, $164,809 in management fees, $157,098 in professional fees, $91,387 in shareholder communications and awareness, and $23,203 in consulting and advisory expenses.

By comparison, our total operating expenses for the six months ended November 30, 2008 were $765,957 including $72,122 in research and development costs, $147,533 in management fees, $165,664 in professional fees, $169,345 in shareholder communications and awareness, and $35,355 in consulting and advisory expenses.
 
5
 
Net Loss

For the six months ended November 30, 2009, we incurred a net loss of $764,174 compared to our net loss of $764,613 for the same period in 2008.  Our net loss per share for the period ended November 30, 2009 was $0.02; the same as for the period ended November 30, 2008.
 
Liquidity and Capital Resources
 
As of November 30, 2009, we had $3,267 cash in our bank accounts and a working capital deficit of $733,203. As of November 30, 2009, we had total assets of $120,677 and total liabilities of $889,287.
 
From January 22, 2007 (date of inception) to November 30, 2009, we raised net proceeds of $2,345,895 in cash from the issuance of common stock and $250,000 for a total of $2,595,895 of cash provided by financing activities for the period.
 
We received net cash of $270,400 from financing activities for the six months ended November 30, 2009 compared to $869,389 for the same period in 2008.  During the period in 2009 we raised cash from the sale of our common stock only, whereas during the period in 2008, we raised $595,000 through the sale of our common stock, $250,000 through the issuance of convertible debentures and $98,595 through borrowings on related party debt.  During the period ended November 30, 2008 we also repaid $74,206 of our related party debt.
 
We used net cash of $270,453 in operating activities for the six months ended November 30, 2009 compared to $717,064 for the same period in 2008.  We used net cash of $2,436,993 in operating activities for the period from January 22, 2007 (date of inception) to November 30, 2009.
 
We did not use any cash in investing activities for the six months November 30, 2009 compared to net cash of $84,990 in investing activities for the same period in 2008 which was used for the purchase of property and equipment.
 
During the six months ended November 30, 2009 we had a decrease of $53 in our cash position compared to an increase of $67,335 for the same period in 2008.  Our monthly cash requirements for six month period ended November 30, 2009 was approximately $45,076 compared to $119,511 for the same period in 2008.  At our current cash position and if this cash requirement continues, we do not have sufficient cash to cover our expenses for one month.
 
On October 16, 17 and 28, 2008, we issued three convertible debentures for total proceeds of $250,000 which bear interest at 10% per annum, are unsecured and due one year from date of issuance. The unpaid amount of principal and accrued interest can be converted at any time at the holder’s option into 625,000 shares of our common stock at a price of $0.40 per share. We also issued 250,000 detachable, non-transferable share purchase warrants. Each share purchase warrant entitles the holder to purchase one additional share of our common stock for a period of two years from the date of the issue at an exercise price of $0.50 per share.  During the period ended November 30, 2009, we recorded accretion expense of $18,382, increasing the carrying value of the convertible debentures to $250,000.
 
On October 1, 2009, we entered into an agreement with an individual to become our Chief Financial Officer for $6,000 per month expiring on September 30, 2010. The individual was also granted 400,000 stock options which are exercisable at $0.20 per share expiring on October 1, 2010.

 
6
 
We expect that our total expenses will increase over the next year as we increase our business operations. We have not been able to reach the break-even point since our inception and have had to rely on outside capital resources. We do not anticipate making significant revenues for the next year. Over the next 12 months, we plan to primarily concentrate on commercializing our ERC technology and associated projects. Below is a summary of our anticipated expenditures over the next 12 months:

Description
Estimated expenses
 ($)
Research and Development
275,000
Consulting Fees
100,000
Acquisition of new technologies
500,000
Commercialization of ERC
1,200,000
Shareholder communication and awareness
250,000
Professional Fees
200,000
Wages and Benefits
150,000
Management Fees
400,000
Total
3,075,000
 
In order to fully carry out our business plan, we need additional financing of approximately $3,075,000 for the next 12 months. In order to improve our liquidity, we intend to pursue additional equity financing from private placement sales of our equity securities or shareholders’ loans. We do not presently have sufficient financing to undertake our planned business activities. Issuances of additional shares will result in dilution to our existing shareholders.
 
We currently do not have any arrangements in place for the completion of any further private placement financings and there is no assurance that we will be successful in completing any further private placement financings. If we are unable to achieve the necessary additional financing, then we plan to reduce the amounts that we spend on our business activities and administrative expenses in order to be within the amount of capital resources that are available to us.
 
Off-Balance Sheet Arrangements
 
We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.
 
Inflation
 
The amounts presented in the financial statements do not provide for the effect of inflation on our operations or financial position. The net operating losses shown would be greater than reported if the effects of inflation were reflected either by charging operations with amounts that represent replacement costs or by using other inflation adjustments.
 
 
7
 
Critical Accounting Policies
 
Our financial statements are impacted by the accounting policies used and the estimates and assumptions made by management during their preparation. A complete summary of these policies is included in note 2 of the notes to our consolidated financial statements for the year ended May 31, 2009 filed in an Annual Report on Form 10-K. We have identified below the accounting policies that are of particular importance in the presentation of our financial position, results of operations and cash flows, and which require the application of significant judgment by management.

Use of Estimates
 
The preparation of financial statements in conformity with US generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We regularly evaluate estimates and assumptions related to allowance for doubtful accounts, the recoverability of intangible and long lived assets, valuation of convertible debt, stock-based compensation and deferred income tax asset valuation allowances. We base our estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by us may differ materially and adversely from our estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
 
Long-lived Assets
 
In accordance with ASC 360, “Impairment or Disposal of Long-Lived Assets”, we test long-lived assets or asset groups for recoverability when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life. Recoverability is assessed based on the carrying amount of the asset and its fair value which is generally determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.
 
Stock-based Compensation
 
We record stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation”, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.
 
We use the Black-Scholes option pricing model to calculate the fair value of stock-based awards. This model is affected by our stock price as well as assumptions regarding a number of subjective variables. These subjective variables include, but are not limited to our expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The value of the portion of the award that is ultimately expected to vest is recognized as an expense in the consolidated statement of operations over the requisite service period.
 
 
8
 
 
Not applicable.
 
 
Evaluation of Disclosure Controls and Procedures
 
We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the "Exchange Act"), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
 
We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of November 30, 2009.  Based on the evaluation of these disclosure controls and procedures, and in light of the weaknesses identified in our internal controls over financial reporting which were enumerated in our Annual Report on Form 10-K for the period ended May 31, 2009, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective.

Changes in Internal Controls

During the period covered by this report there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
 
 
9
 
 
Item 1. Legal Proceedings.
 
We are not aware of any material legal proceedings which involve Mantra or any of its properties or subsidiaries.
 
 
From September 1, 2009 to November 30, 2009, we made the following previously unreported sales of unregistered securities:
 
·  
On October 15, 2009, we issued 68,000 units at $0.15 per unit for proceeds of $10,200. Each unit consisted of one share of common stock and one non-transferable share purchase warrant to purchase one additional share of common stock at an exercise price of $0.30 per share expiring on the earlier of two years or five business days after our common stock trades at least one time per day on the FINRA Over the Counter Bulletin Board at a price at or above $0.60 per share for seven consecutive trading days.  These shares were issued without a prospectus pursuant to exemptions from registration found in Regulation S of the Securities Act of 1933, as amended.
 
·  
On November 27, 2009, we issued 556,000 units at $0.15 per unit for proceeds of $83,400. Each unit consisted of one share of common stock and one non-transferable share purchase warrant to purchase one additional share of common stock at an exercise price of $0.30 per share expiring on the earlier of two years or five business days after our common stock trades at least one time per day on the FINRA Over the Counter Bulletin Board at a price at or above $0.60 per share for seven consecutive trading days.  These shares were issued without a prospectus pursuant to exemptions from registration found in Regulation S of the Securities Act of 1933, as amended.
 
·  
On October 1, 2009 we issued options to acquire 400,000 shares of our common stock at $0.20 per share to our current CFO.  The options expire in 1 year, or upon the termination of our consulting agreement with our CFO. These shares were issued without a prospectus pursuant to exemptions from registration found in Regulation S of the Securities Act of 1933, as amended.
 
We completed the offerings of the common stock pursuant to Rule 903 of Regulation S of the Securities Act on the basis that the sale of the common stock was completed in an "offshore transaction", as defined in Rule 902(h) of Regulation S. We did not engage in any directed selling efforts, as defined in Regulation S, in the United States in connection with the sale of the units. Each investor was not a US person, as defined in Regulation S, and was not acquiring the shares for the account or benefit of a US person.
 
 
10
 
 
None.
 
 
None.
 
 
None
 
 
 
(1)  
Attached as an exhibit to our current report on Form 8-K filed on November 6, 2009.
 
(2)  
Attached as an exhibit to our current report on Form 8-K filed on October 7, 2009
 
 
 
11
 
SIGNATURES
 
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
Mantra Venture Group Ltd.
 
(Registrant)
   
 
/s/ Larry Kristof
Date: January 14, 2010
Larry Kristof
 
President, Chief Executive Officer, Director
   
 
/s/ Con Buckley
Date: January 14, 2010
Con Buckley
 
Chief Financial Officer, Principal Accounting Officer

12